Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia

Modern Pathology

Volumn 21, Issue 7, 2008, Pages 837-846

  Van Huyen, Jean Paul Duong ^a,b,e   Smadja, David M ^a,b   Bruneval, Patrick ^a,b   Gaussem, Pascale ^a,b   Dal Cortivo, Liliane ^a,c,d   Julia, Pierre ^a,b   Fiessinger, Jean Noël ^a,b   Cavazzana Calvo, Marina ^a,c,d   Aiach, Martine ^a,b   Emmerich, Joseph ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSERM   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Angiogenesis; Bone marrow mononuclear cells; Cell therapy; Ischemia; Peripheral artery disease

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; KI 67 ANTIGEN; PODOPLANIN; STEM CELL FACTOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL PROLIFERATION; CELL THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEG AMPUTATION; LEG ISCHEMIA; LYMPH VESSEL; MALE; MONONUCLEAR CELL; MULTICENTER STUDY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AMPUTATION; ANTIGENS, CD31; ANTIGENS, CD34; BIOLOGICAL MARKERS; BLOOD VESSELS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; ISCHEMIA; LEG; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 46049083232     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.48     Document Type: Article

References (32)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans-Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654.
2. Opie SR, Dib N. Local endovascular delivery, gene therapy, and cell transplantation for peripheral arterial disease. J Endovasc Ther 2004;11(Suppl 2):II151-II162.
3. Emmerich J. Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy. Int J Low Extrem Wounds 2005;4:234-241.
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660.
5. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
6. Ho TK, Rajkumar V, Ponticos M, et al. Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia. J Vasc Surg 2006;43:125-133.
7. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation 2004;109:2487-2491.
8. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004;109:2692-2697.
9. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
10. Gulati R, Jevremovic D, Peterson TE, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003;93:1023-1025.
11. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-1627.
12. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-435.
13. Higashi Y, Kimura M, Hara K, et al. Autologous bone marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004;109:1215-1218.
14. Saigawa T, Kato K, Ozawa T, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004;68:1189-1193.
15. Huang PP, Li SZ, Han MZ, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost 2004;91:606-609.
16. Huang P, Li S, Han M, et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005;28:2155-2160.
17. Beaujean F, Hartmann O, Kuentz M, et al. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991;8:291-294.
18. Preti RA, Ahmed T, Ayello J, et al. Hemopoietic stem cell processing: comparison of progenitor cell recovery using the Cobe 2991 cell washer and the Haemonetics V50 apheresis system. Bone Marrow Transplant 1992;9:377-381.
19. Van Huyen JP, Batisse D, Heudes D, et al. Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients. Mod Pathol 2006;19:1277-1288.
20. Hansen S, Graban DA, Sorensen FB, et al. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 2000;6:139-146.
21. Al-Rawi MA, Mansel RE, Jiang WG. Molecular and cellular mechanisms of lymphangiogenesis. Eur J Surg Oncol 2005;31:117-121.
22. Heissig B, Werb Z, Rafii S, et al. Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thromb Haemost 2003;90:570-576.
23. Kinnaird T, Stabile E, Burnett MS, et al. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 2004;95:354-363.
24. Zentilin L, Tafuro S, Zacchigna S, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006;107:3546-3554.
25. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
26. Smadja DM, Laurendeau I, Avignon C, et al. The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost 2006;2051-2058.
27. Rajagopalan S, Mohler III ER, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003;108:1933-1938.
28. Makinen K, Manninen H, Hedman M, et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002;6:127-133.
29. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901.
30. Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996;348:370-374.
31. Pignon B, Sevestre MA, Chatelain D, et al. Histological changes after implantation of autologous bone marrow mononuclear cells for critical leg ischemia. Bone Marrow Transplant 2007;39:647-648.
32. Sainz J, Sata M. Maintenance of vascular homeostasis by bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2006;26:1196-1197.